Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Inflammatory Bowel Diseases"" wg kryterium: Temat


Tytuł :
Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
Autorzy :
Behzad C; Clinical Research and Development Unit, Rouhani University Hospital, Babol University of Medical Sciences, Babol, Iran.
Taheri H; Department of Gastroenterology, Babol University of Medical Sciences, Babol, Iran.
Kashifard M; Department of Gastroenterology, Babol University of Medical Sciences, Babol, Iran.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. e140.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Coronavirus Infections*
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*
Pneumonia, Viral*
Betacoronavirus ; Humans ; Italy ; Quality of Health Care
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
Autorzy :
Zhang X; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Wang S; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ding X; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guo J; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Tian Z; Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Pokaż więcej
Źródło :
Scandinavian journal of immunology [Scand J Immunol] 2020 Sep; Vol. 92 (3), pp. e12897. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*/methods
Inflammatory Bowel Diseases/*therapy
Animals ; Biomarkers ; Combined Modality Therapy ; Genetic Engineering ; Humans ; Inflammatory Bowel Diseases/etiology ; Inflammatory Bowel Diseases/metabolism ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/metabolism ; Organ Specificity ; Phenotype ; Transplantation Conditioning/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[DISABILITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS SECTIONAL STUDY].
Autorzy :
Reches L; Medical Corps, Israeli Defense Forces.
Israeli E; Institute of Gastroenterology and Liver Diseases, E. Wolfson Medical Center, Holon.; Sackler Faculty of Medicine, Tel- Aviv University, Tel Aviv.
Pokaż więcej
Źródło :
Harefuah [Harefuah] 2020 Nov; Vol. 159 (11), pp. 815-819.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Cross-Sectional Studies ; Humans ; Israel/epidemiology ; Quality of Life ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden.
Autorzy :
Nguyen LH; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Örtqvist AK; Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden; Department of Obstetrics and Gynecology, Visby Lasarett, Gotland, Sweden.
Cao Y; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Alvin J Siteman Cancer Centre, Washington University School of Medicine, St Louis, MO, USA; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
Simon TG; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Roelstraete B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Song M; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Nutrition, Harvard T H Chan School of Public Health, Boston, MA, USA.
Joshi AD; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Staller K; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Chan AT; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Disease, Harvard T H Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Khalili H; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Olén O; Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden; Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden.
Ludvigsson JF; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Paediatrics, Örebro University Hospital, Örebro, Sweden; Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Nov; Vol. 5 (11), pp. 986-995. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents*/classification
Anti-Bacterial Agents*/therapeutic use
Dysbiosis*/chemically induced
Dysbiosis*/prevention & control
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/pathology
Adolescent ; Adult ; Age of Onset ; Antimicrobial Stewardship ; Biopsy/statistics & numerical data ; Case-Control Studies ; Clinical Pharmacy Information Systems/statistics & numerical data ; Female ; Humans ; Male ; Prospective Studies ; Risk Assessment/methods ; Risk Factors ; Siblings ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
Autorzy :
Prentice RE; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia.
Al-Ani AH; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia.
Bond K; Department of Infectious Diseases, The Royal Melbourne Hospital, Melbourne, Vic., Australia.
Johnson D; Department of Infectious Diseases, The Royal Melbourne Hospital, Melbourne, Vic., Australia.
Christensen B; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2020 Nov; Vol. 52 (11), pp. 1250-1251. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus Infections*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Pandemics*
Pneumonia, Viral*
SARS Virus*
Betacoronavirus ; Biological Therapy/adverse effects ; Humans ; Immunization
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
Autorzy :
Fantini MC; Gastroenterology Unit, University Hospital, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Biancone L; Gastroenterology Unit, Policlinico Tor Vergata. Department of Systems Medicine, University of Rome, Rome, Italy.
Dragoni G; Gastroenterology Unit, Azienda Ospedaliero Universitaria Careggi, Firenze, Toscana, Italy.
Bezzio C; Gastroenterology Unit, Rho Hospital, Rho (MI), ASST Rhodense, Garbagnate Milanese, Lombardia, Italy.
Miranda A; Gastroenterology and Endoscopy Unit, University of Campania 'L. Vanvitelli' Naples, Italy.
Ribaldone DG; Department of Medical Sciences, University of Turin, Turin, Italy.
Bertani A; Department of Gastroenterology, IBD Unit, Policlinico Hospital, Modena, Italy.
Bossa F; Division of Gastroenterology, IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Puglia, Italy.
Allocca M; IBD Center, Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Buda A; Department of Gastrointestinal Oncological Surgery, Gastroenterology and Endoscopy Unit, S. Maria del Prato Hospital, Feltre, Italy.
Mocci G; SC Gastroenterologia Ospedale Brotzu, Cagliari, Italy.
Soriano A; Gastroenterology Division, Azienda USL Arcispedale S. Maria Nuova, IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Guglielmi FW; Section of Gastroenterology & Artificial Nutrition, Hospital San Nicola Pellegrino, Bari, Italy.
Bertani L; Gastroenterology and Digestive Endoscopy Department of Medical Specialties Apuane Hospital, Tuscany North-West ASL, Massa, Italy.
Baccini F; Digestive Disease Unit, Sant'Andrea University Hospital, Rome, Italy.
Loddo E; Gastroenterology Unit, University Hospital, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Privitera AC; IBD Unit Azienda Ospedaliera per l'Emergenza 'Cannizzaro,' Catania, Italy.
Sartini A; Gastroenterology and Digestive Endoscopy Unit, Forlì-Cesena, AUSL della Romagna, Italy.
Viscido A; Gastroenterology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Grossi L; G. D'Annunzio University-Digestive Physiopathology Ospedale Spirito Santo Pescara, Pescara, Italy.
Casini V; ASST BERGAMO EST, Ospedale Seriate, UOC Gastroenterologia ed Endoscopia Digestiva, Bergamo, Italy.
Gerardi V; Department of Medicine, Gastroenterology and Endoscopy, Fondazione Poliambulanza, Brescia, Italy.
Ascolani M; Gastroenterology Unit, Ospedale Santa Maria di Ca Foncello, Treviso, Veneto, Italy.
Di Ruscio M; IBD Unit, IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.
Casella G; Gastroenterologist, General Practitioner, Limbiate (Monza Brianza), ATS Lecco Brianza, Lombardia, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Stradella D; Gastroenterologia, A.O.U Maggiore della Caritá di Novara, Piemonte, University of Eastern Piedmont Amedeo Avogadro, Italy.
Pumpo R; Endoscopia Digestiva, P.O. S.G. Bosco, ASLNA1, Napoli, Campania, Italy.
Cortelezzi CC; SC di Gastroneterologia ed Endoscopia Digestiva Ospedale di Circolo Fondazione Macchi ASST Sette Laghi Varese, Italy.
Daperno M; Gastroenterology Unit, Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Piemonte, Italy.
Ciardo V; Struttura Operativa Semplice Dipartimentale (SOSD) di Gastroenterologia, AAS3 Alto Friuli Collinare e Medio Friuli, Ospedale di San Daniele del Friuli, Italy.
Nardone OM; Gastroenterology, Federico II University Hospital, Napoli, Campania, Italy.
Caprioli F; Gastroenterology and Endoscopy Unit, La Fondazione IRCCS Ca' Granda Ospedale Maggiore di Milano Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milano, Lombardia, Italy.
Vitale G; Gastroenterology and Endoscopy Unit, 'San Carlo' Hospital, Potenza, Italy.
Cappello M; Head IBD Clinic, Gastroenterology Section, Promise, University of Palermo, Sicily, Italy.
Comberlato M; Divisione di Gastrenterologia e Servizio di Fisiopatologia ed Endoscopia digestiva Ambulatorio interdisciplinare per le malattie infiammatorie croniche intestinali, Ospedale provinciale - Bolzano, Italy.
Alvisi P; Pediatric Department, Maggiore Hospital, Bologna, Italy.
Festa S; S. Filippo Neri Hospital, IBD Unit, Rome, Lazio, Italy.
Campigotto M; Diparimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute, Università degli Studi di Trieste, Trieste, Italy.
Bodini G; Cattedra di Gastroenterologia, Diparti-mento di Medicina Interna, Universita`di Genova, Genova, Italy.
Balestrieri P; Unit of Digestive Disease of Campus Bio Medico University of Rome, Italy.
Viola A; UOSD Malattie Intestinali Croniche, Dip. di Medicina Clinica e Sperimentale, Policlinico Messina, Sicily, Italy.
Pugliese D; CEMAD - IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Armuzzi A; CEMAD - IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Saibeni S; Gastroenterology Unit, Rho Hospital, Rho (MI), ASST Rhodense, Garbagnate Milanese, Lombardia, Italy.
Fiorino G; IBD Center, Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. e134-e136.
Typ publikacji :
Letter
MeSH Terms :
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Hospital Units*/organization & administration
Hospital Units*/statistics & numerical data
Hospital Units*/trends
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*/prevention & control
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Telemedicine*/methods
Telemedicine*/organization & administration
Infection Control/*methods
Mass Screening/*methods
Aftercare/methods ; Aftercare/organization & administration ; Betacoronavirus ; Hospitalization/statistics & numerical data ; Humans ; Italy/epidemiology ; Organizational Innovation ; Remote Consultation/methods ; Surveys and Questionnaires
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
Autorzy :
Viganò C; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Massironi S; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Pirola L; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Cristoferi L; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Fichera M; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Bravo M; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Mauri M; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Redaelli AE; Interventional Endoscopy Unit, San Gerardo Hospital, University of Milano, Bicocca School of Medicine, Monza, Italy.
Dinelli ME; Interventional Endoscopy Unit, San Gerardo Hospital, University of Milano, Bicocca School of Medicine, Monza, Italy.
Invernizzi P; Division of Gastroenterology and Center for Autoimmune Liver Diseases; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. e138-e139.
Typ publikacji :
Letter; Observational Study
MeSH Terms :
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Inflammatory Bowel Diseases*/classification
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*/prevention & control
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Immunosuppressive Agents/*therapeutic use
Risk Adjustment/*methods
Betacoronavirus/isolation & purification ; Clinical Laboratory Techniques/methods ; Clinical Laboratory Techniques/statistics & numerical data ; Contact Tracing/methods ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Prevalence ; Risk Factors ; Symptom Assessment/methods
SCR Disease Name :
COVID-19
Raport
Tytuł :
Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
Autorzy :
Eltabbakh MM; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Shamkh MAA; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Bassuny AN; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abd Alaty WH; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Sakr MA; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Sherief AF; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. 1771-1778.
Typ publikacji :
Editorial
MeSH Terms :
Aftercare*/methods
Aftercare*/organization & administration
Communicable Disease Control*/methods
Communicable Disease Control*/standards
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*/prevention & control
Patient Care Management*/methods
Patient Care Management*/trends
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Hospital Units/*organization & administration
Adult ; Betacoronavirus ; Comorbidity ; Egypt/epidemiology ; Female ; Humans ; Immunologic Factors/therapeutic use ; Incidence ; Male ; Organizational Innovation ; Practice Guidelines as Topic ; Severity of Illness Index
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic.
Autorzy :
Kornbluth A; The Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Kissous-Hunt M; The Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
George J; The Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Legnani P; The Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. 1779-1785.
Typ publikacji :
Journal Article
MeSH Terms :
Communicable Disease Control*/methods
Communicable Disease Control*/organization & administration
Coronavirus Infections*/diagnosis
Coronavirus Infections*/drug therapy
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Coronavirus Infections*/transmission
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*
Patient Care Management*/methods
Patient Care Management*/organization & administration
Patient Care Management*/trends
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Pneumonia, Viral*/transmission
Adult ; Aftercare/methods ; Aftercare/organization & administration ; Betacoronavirus/isolation & purification ; Clinical Laboratory Techniques/methods ; Cohort Studies ; Disease Transmission, Infectious/prevention & control ; Female ; Humans ; Male ; Mortality ; New York City/epidemiology ; Organizational Innovation ; Outcome and Process Assessment, Health Care ; Telemedicine/methods
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
Autorzy :
Horrigan JM; Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Siegel CA; Department of Medicine, Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Tadros M; Department of Medicine, Division of Gastroenterology and Hepatology, Albany Medical College, Albany, NY, USA.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Oct 23; Vol. 26 (11), pp. e137.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus Infections*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Pandemics*
Pneumonia, Viral*
Betacoronavirus ; Humans ; Italy
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
Autorzy :
Siegel CA; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock IBD Center, Lebanon, NH, USA.
Christensen B; Gastroenterology Department, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Kornbluth A; Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rosh JR; Division of Pediatric Gastroenterology, Goryeb Children's Hospital, Morristown, NJ, USA.
Kappelman MD; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ungaro RC; Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Johnson DF; Departments of Infectious Diseases and Internal Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Chapman S; Department of Infectious Diseases, St Vincent's Hospital, Sydney, NSW, Australia.
Wohl DA; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Mantzaris GJ; Department of Gastroenterology, Evaggelismos-Ophthalmiatreion Athinon-Polykliniki GHA, Athens, Greece.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Oct 21; Vol. 14 (Supplement_3), pp. S769-S773.
Typ publikacji :
Consensus Development Conference; Journal Article; Practice Guideline
MeSH Terms :
Betacoronavirus*/isolation & purification
Clinical Laboratory Techniques*
Immunocompromised Host*
Coronavirus Infections/*immunology
Coronavirus Infections/*prevention & control
Immunosuppressive Agents/*administration & dosage
Inflammatory Bowel Diseases/*drug therapy
Pandemics/*prevention & control
Pneumonia, Viral/*immunology
Pneumonia, Viral/*prevention & control
Asymptomatic Infections ; Coronavirus Infections/diagnosis ; Drug Administration Schedule ; Humans ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Inflammatory Bowel Diseases/immunology ; Pneumonia, Viral/diagnosis ; Risk Assessment
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
Autorzy :
Wang H; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Tu L; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Li Y; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Bai T; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Zou K; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Xiao F; Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Li J; Department of Gastroenterology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, China.
Chen M; Department of Gastroenterology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, China.
Zhang H; Department of Gastroenterology, The Central Hospital of Wuhan, Wuhan, Hubei Province, China.
Li G; Department of Gastroenterology, The Eighth Hospital of Wuhan, Wuhan, Hubei Province, China.
Lu Y; Department of Gastroenterology, The First Affiliated Hospital of Changjiang University, Jingzhou, Hubei Province, China.
Wang K; Department of Gastroenterology, Jingzhou Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jingzhou, Hubei Province, China.
Jin S; Department of Gastroenterology, Taihe Hospital, Huei University of medicine, Shiyan, Hubei Province, China.
Yang Y; Department of Gastroenterology, Yichang Central Hospital, Yichang, Hubei, China.
Zhu L; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Hou X; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Pokaż więcej
Źródło :
Journal of immunology research [J Immunol Res] 2020 Oct 09; Vol. 2020, pp. 2847316. Date of Electronic Publication: 2020 Oct 09 (Print Publication: 2020).
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Health Services Accessibility*
Coronavirus Infections/*epidemiology
Inflammatory Bowel Diseases/*drug therapy
Inflammatory Bowel Diseases/*epidemiology
Pneumonia, Viral/*epidemiology
Adult ; Anxiety/psychology ; Betacoronavirus/drug effects ; China/epidemiology ; Cross-Sectional Studies ; Depression/psychology ; Female ; Humans ; Inflammatory Bowel Diseases/pathology ; Male ; Pandemics ; Quality of Life/psychology ; Surveys and Questionnaires
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Review of inflammatory bowel disease and COVID-19.
Autorzy :
Sultan K; Division of Gastroenterology, Northwell Health, North Shore University Hospital and Long Island Jewish Medical Center, Great Neck, NY 10021, United States.
Mone A; Department of Gastroenterology, Northwell Health, Lenox Hill Hospital, New York, NY 10075, United States.
Durbin L; Department of Medicine, Northwell Health, Lenox Hill Hospital, New York, NY 10075, United States.
Khuwaja S; Department of Medicine, Northwell Health, Long Island Jewish Forest Hills Hospital, Queens, NY 11375, United States. .
Swaminath A; Division of Gastroenterology, Northwell Health, Lenox Hill Hospital, New York, NY 10075, United States.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2020 Oct 07; Vol. 26 (37), pp. 5534-5542.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Betacoronavirus*
Coronavirus Infections/*prevention & control
Inflammatory Bowel Diseases/*complications
Inflammatory Bowel Diseases/*therapy
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
Coronavirus Infections/diagnosis ; Coronavirus Infections/etiology ; Coronavirus Infections/therapy ; Global Health ; Humans ; Inflammatory Bowel Diseases/immunology ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/etiology ; Pneumonia, Viral/therapy ; Risk Assessment ; Risk Factors
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Close homolog of L1-deficient ameliorates inflammatory bowel disease by regulating the balance of Th17/Treg.
Autorzy :
Yao J; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Gao R; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Luo M; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Li D; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Guo L; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Yu Z; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Xiong F; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Wei C; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Wu B; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Xu Z; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Zhang D; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China. Electronic address: .
Wang J; Department of General Surgery, Shenzhen Children's Hospital, No. 7019, Yitian Road, Shenzhen City, Guangdong Province 518026, China.
Wang L; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, No. 1017, East Gate Road, Shenzhen City, Guangdong Province 518020, China.
Pokaż więcej
Źródło :
Gene [Gene] 2020 Oct 05; Vol. 757, pp. 144931. Date of Electronic Publication: 2020 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Adhesion Molecules/*genetics
Inflammatory Bowel Diseases/*genetics
T-Lymphocytes, Regulatory/*immunology
Th17 Cells/*immunology
Animals ; Cell Adhesion Molecules/deficiency ; Cell Differentiation ; Forkhead Transcription Factors/genetics ; Forkhead Transcription Factors/metabolism ; Inflammatory Bowel Diseases/blood ; Inflammatory Bowel Diseases/immunology ; Interleukins/genetics ; Interleukins/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Nuclear Receptor Subfamily 1, Group F, Member 3/genetics ; Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; T-Lymphocytes, Regulatory/cytology ; Th17 Cells/cytology
Czasopismo naukowe
Tytuł :
COVID-19 Outbreak and Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice.
Autorzy :
Bai X; Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Yang H; Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Qian J; Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Oct 05; Vol. 14 (10), pp. 1494-1495.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Mobile Applications*
Pandemics*/prevention & control
Patient Care Management*/organization & administration
Patient Care Management*/trends
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Remote Consultation*/instrumentation
Remote Consultation*/methods
Adult ; Betacoronavirus ; China/epidemiology ; Female ; Humans ; Male ; Monitoring, Physiologic/trends ; Organizational Innovation ; Patient Navigation/trends ; Surveys and Questionnaires
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Endoscopic Evaluation of Inflammatory Bowel Disease With High-Grade Dysplasia Should Not Be Delayed During the COVID-19 Pandemic: A Case Report.
Autorzy :
Raphael KL; Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, New York, USA.
Trindade AJ; Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, New York, USA.
Zimmerman HM; Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, New York, USA.
Sultan KS; Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, New York, USA.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2020 Oct; Vol. 115 (10), pp. 1727-1728.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Coronavirus Infections/*prevention & control
Endoscopy/*standards
Infection Control/*standards
Inflammatory Bowel Diseases/*diagnosis
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
Time-to-Treatment/*standards
Betacoronavirus/pathogenicity ; Colectomy/standards ; Colon/diagnostic imaging ; Colon/pathology ; Coronavirus Infections/epidemiology ; Coronavirus Infections/transmission ; Coronavirus Infections/virology ; Disease Progression ; Female ; Humans ; Inflammatory Bowel Diseases/pathology ; Inflammatory Bowel Diseases/surgery ; Intestinal Mucosa/diagnostic imaging ; Intestinal Mucosa/pathology ; Middle Aged ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/transmission ; Pneumonia, Viral/virology
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
Autorzy :
Garg M; Department of Gastroenterology, Northern Hospital, Melbourne, Victoria, Australia; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Christensen B; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Lubel JS; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2020 Oct; Vol. 159 (4), pp. 1623-1624.e3. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus Infections*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Pandemics*
Pneumonia, Viral*
SARS Virus*
Betacoronavirus ; Humans ; Peptidyl-Dipeptidase A
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
Autorzy :
Stallmach A; Klinik für Innere Medizin IV (Gastroenterologie, Infektiologie und Hepatologie), Universitätsklinikum Jena, Jena.
Sturm A; Klinik für Innere Medizin, Schwerpunkt Gastroenterologie, DRK Kliniken Berlin | Westend, Berlin.
Blumenstein I; Medizinische Klinik 1 (Gastroenterologie und Hepatologie, Pneumologie und Allergologie, Endokrinologie und Diabetologie sowie Ernährungsmedizin), Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt.
Helwig U; Internistische Praxengemeinschaft Oldenburg, Oldenburg.
Koletzko S; Kinderklinik und Kinderpoliklinik im Dr. von Hauner Kinderspital, LMU Klinikum der Universität München, München.
Lynen P; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen, Berlin.
Schmidt C; Medizinische Klinik II (Gastroenterologie, Hepatologie, Endokrinologie, Diabetologie und Infektiologie), Klinikum Fulda, Universitätsmedizin Marburg - Campus Fulda, Fulda.
Dignass A; Medizinische Klinik I, Agaplesion Markus Krankenhaus, Frankfurt.
Kucharzik T; Klinik für Innere Medizin, Gastroenterologie, Klinikum Lüneburg, Lüneburg.
Pokaż więcej
Transliterated Title :
Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten.
Corporate Authors :
Collaborators:
Źródło :
Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2020 Oct; Vol. 58 (10), pp. 982-1002. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/therapy
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Crohn Disease*/diagnosis
Crohn Disease*/therapy
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/therapy
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Practice Guidelines as Topic*
Betacoronavirus ; Germany ; Humans ; Pandemics
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
Autorzy :
Caron B; Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, Hôpitaux Universitaires de Strasbourg (HUS), Hôpital de Hautepierre, Strasbourg, France; INSERM U1113 IRFAC (Interface de Recherche, Fondamentale et Appliquée en Cancérologie), Université de Strasbourg, Faculté de Médecine, Strasbourg, France.
Arondel Y; Service d'Hépato-gastro-entérologie et d'Endoscopie digestive, Centre Hospitalier de Haguenau, Haguenau, France.
Reimund JM; Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, HUS, Hôpital de Hautepierre, Strasbourg, France; INSERM U1113 IRFAC (Interface de Recherche, Fondamentale et Appliquée en Cancérologie), Université de Strasbourg, Faculté de Médecine, Strasbourg, France; Institut Hospitalo-Universitaire de Strasbourg, HUS, Strasbourg, France.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Oct; Vol. 18 (11), pp. 2637-2638. Date of Electronic Publication: 2020 Jun 06.
Typ publikacji :
Letter; Multicenter Study
MeSH Terms :
Betacoronavirus*
Disease Management*
Coronavirus Infections/*epidemiology
Inflammatory Bowel Diseases/*epidemiology
Pneumonia, Viral/*epidemiology
Adult ; Comorbidity ; Europe/epidemiology ; Female ; Humans ; Incidence ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/therapy ; Male ; Middle Aged ; Pandemics ; Severity of Illness Index
SCR Disease Name :
COVID-19
Raport
Tytuł :
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience.
Autorzy :
Fiorino G; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Allocca M; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Furfaro F; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Gilardi D; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Zilli A; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Radice S; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Spinelli A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Division of Colon and Rectal Surgery, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Danese S; Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Sep 16; Vol. 14 (9), pp. 1330-1333.
Typ publikacji :
Journal Article
MeSH Terms :
Communicable Disease Control*/methods
Communicable Disease Control*/organization & administration
Coronavirus Infections*/epidemiology
Coronavirus Infections*/prevention & control
Coronavirus Infections*/psychology
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Pandemics*/prevention & control
Patient Care Management*/organization & administration
Patient Care Management*/standards
Patient Care Management*/trends
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/prevention & control
Pneumonia, Viral*/psychology
Quality Assurance, Health Care*/methods
Quality Assurance, Health Care*/organization & administration
Betacoronavirus ; Change Management ; Humans ; Italy/epidemiology ; Patient Education as Topic ; Risk Reduction Behavior
SCR Disease Name :
COVID-19
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies